These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37454926)

  • 1. Differences in Mortality Among Patients With Asthma and COPD Hospitalized With COVID-19.
    Liu Y; Rajeevan H; Simonov M; Lee S; Wilson FP; Desir GV; Vinetz JM; Yan X; Wang Z; Clark BJ; Possick JD; Price C; Lutchmansingh DD; Ortega H; Zaeh S; Gomez JV; Cohn L; Gautam S; Chupp GL
    J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3383-3390.e3. PubMed ID: 37454926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.
    Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes Among Patients Hospitalized With Non-COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada.
    McAlister FA; Chu A; Qiu F; Dong Y; van Diepen S; Youngson E; Yu AYX; de Mestral C; Ross HJ; Austin PC; Lee DS; Kadri SS; Wijeysundera HC;
    JAMA Netw Open; 2023 Jul; 6(7):e2323035. PubMed ID: 37436751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the role of obstructive pulmonary diseases and eosinophil count at admission on all-cause mortality in SARS-CoV-2 patients : A single center registry-based retrospective cohort study.
    Salai G; Vrazic H; Kovacevic I; Janes LM; Marasovic I; Ranilovic D; Vukoja D; Zelenika Margeta M; Huljev-Sipos I; Lalic K; Spoljaric M; Tekavec-Trkanjec J; Vergles M; Lucijanic M; Luksic I; Ljubicic D
    Wien Klin Wochenschr; 2023 May; 135(9-10):235-243. PubMed ID: 37093279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
    Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
    Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.
    Pérez de Llano L; Cosío BG; Miravitlles M; Plaza V;
    Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):198-204. PubMed ID: 29229474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of severe coronavirus disease 2019 patients with chronic obstructive pulmonary disease.
    Liang H; Lu R; Li Y; Pan P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1695-1703. PubMed ID: 36748380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophils and chronic obstructive pulmonary diseases (COPD) in hospitalized COVID-19 patients.
    Fekri MS; Najminejad Z; Karami Robati F; Dalfardi B; Lashkarizadeh M; Najafzadeh MJ
    BMC Infect Dis; 2024 Jun; 24(1):553. PubMed ID: 38831292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.
    Song J; Zeng M; Wang H; Qin C; Hou HY; Sun ZY; Xu SP; Wang GP; Guo CL; Deng YK; Wang ZC; Ma J; Pan L; Liao B; Du ZH; Feng QM; Liu Y; Xie JG; Liu Z
    Allergy; 2021 Feb; 76(2):483-496. PubMed ID: 32716553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
    Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
    Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population.
    Huang BZ; Chen Z; Sidell MA; Eckel SP; Martinez MP; Lurmann F; Thomas DC; Gilliland FD; Xiang AH
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3621-3628.e2. PubMed ID: 34389242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
    COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap on the prognosis of coronavirus disease 2019.
    Shin E; Jin J; Park SY; Yoo YS; Lee JH; An J; Song WJ; Kwon HS; Cho YS; Moon HB; Lee JB; Kim TB
    Asia Pac Allergy; 2022 Apr; 12(2):e21. PubMed ID: 35571550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
    Cosío BG; Pérez de Llano L; Lopez Viña A; Torrego A; Lopez-Campos JL; Soriano JB; Martinez Moragon E; Izquierdo JL; Bobolea I; Callejas J; Plaza V; Miravitlles M; Soler-Catalunya JJ;
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28461299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis.
    Toppen W; Yan P; Markovic D; Shover CM; Buhr RG; Fulcher JA; Tashkin DP; Barjaktarevic I
    Int J Chron Obstruct Pulmon Dis; 2022; 17():3111-3121. PubMed ID: 36570857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma.
    Abe Y; Suzuki M; Kimura H; Shimizu K; Takei N; Oguma A; Matsumoto-Sasaki M; Goudarzi H; Makita H; Nishimura M; Konno S
    Allergol Int; 2023 Jul; 72(3):402-410. PubMed ID: 36586746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exacerbation of obstructive pulmonary diseases by SARS-CoV-2 infection in patients treated in the Pulmonology Clinic of Târgu Mures].
    Szathmáry M; Gîrbovan EC; Sárközi HK; Gáll Z; Vultur MA; Nemeș AF; Ianoși ES; Jimborean G
    Orv Hetil; 2023 Jan; 164(2):43-50. PubMed ID: 36641756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.
    Schultze A; Walker AJ; MacKenna B; Morton CE; Bhaskaran K; Brown JP; Rentsch CT; Williamson E; Drysdale H; Croker R; Bacon S; Hulme W; Bates C; Curtis HJ; Mehrkar A; Evans D; Inglesby P; Cockburn J; McDonald HI; Tomlinson L; Mathur R; Wing K; Wong AYS; Forbes H; Parry J; Hester F; Harper S; Evans SJW; Quint J; Smeeth L; Douglas IJ; Goldacre B;
    Lancet Respir Med; 2020 Nov; 8(11):1106-1120. PubMed ID: 32979987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of the SOFA score in patients with COVID-19: A retrospective, observational study.
    Yang Z; Hu Q; Huang F; Xiong S; Sun Y
    Medicine (Baltimore); 2021 Aug; 100(32):e26900. PubMed ID: 34397917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.